The Ocular Melanoma Foundation (OMF) is committed to accelerating scientific research and awareness of melanoma in the eye and to providing education and support to patients, their families and medical professionals.

Announcements

  • The 2017 EANA Patient Retreat is moving west to sunny California at the end of this month! Hosted in collaboration with Stanford Eye Institute and Dr. Prithvi Mruthyunjaya, OMF will welcome patients and caregivers from around the world October 27-29 in Palo Alto. Register TODAY >

  • OMF's strategic partner, Aura Biosciences, recently received clearance from the U.S. FDA to conduct a clinical trial using targeted therapy. This study for light-activated AU-011 for the treatment of patients with small-to-medium primary ocular melanoma is now enrolling in five locations across the country. To learn more, visit www.clinicaltrials.gov or contact clinical@aurabiosciences.com.

Raising Awareness of Eye Health